Ondansetron [Oral Soluble Film]

Ondansetron is a 5-HT3 receptor antagonist indicated for:

Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy.
Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
Prevention of nausea and vomiting associated with radiotherapy in patients receiving total body irradiation, single high-dose fraction to abdomen, or daily fractions to the abdomen.
Prevention of postoperative nausea and/or vomiting.

There are no products to list in this category.